Effects of extracellular magnesium on the differentiation and function of human osteoclasts

Acta Biomaterialia

Volumn 10, Issue 6, 2014, Pages 2843-2854

  Wu, Lili ^a,b   Luthringer, Bérengère J C ^a   Feyerabend, Frank ^a   Schilling, Arndt F ^b   Willumeit, Regine ^a  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biodegradation; Cell culture; Magnesium; Osteoclast; Primary cells

Indexed keywords

BIODEGRADATION; CELL PROLIFERATION; CHLORINE COMPOUNDS; MAGNESIUM COMPOUNDS; METABOLISM; PHOSPHATASES;

BONE STRUCTURE; CELL/B.E; CELLULAR MECHANISMS; EXTRACELLULAR; IN-VITRO; MAGNESIUM CONCENTRATIONS; METABOLIC ACTIVITY; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELLS; PRIMARY CELLS;

CELL CULTURE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; MAGNESIUM; ACID PHOSPHATASE; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE;

ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; OSTEOCLAST;

ACID PHOSPHATASE; CATHEPSIN K; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; ISOENZYMES; MAGNESIUM; OSTEOCLASTS; RECEPTORS, CALCITONIN;

EID: 84899654030     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.02.010     Document Type: Article

References (62)

1. Zeng R, Dietzel W, Witte F, Hort N, Blawert C. Progress and challenge for magnesium alloys as biomaterials. Adv Biomater 2008;10:B3-B14.
2. Peuster M, Beerbaum P, Bach FW, Hauser H. Are resorbable implants about to become a reality? Cardiol Young 2006;16:107-16.
3. Gu X, Zheng Y, Cheng Y, Zhong S, Xi T. In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials 2009;30:484-98.
4. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010;5(Suppl. 1):S23-30.
5. Wallach S. Availability of body magnesium during magnesium deficiency. Magnesium 1988;7:262-70.
6. Altura BM. Basic biochemistry and physiology of magnesium: a brief review. Magnes Trace Elem 1991;10:167-71.
7. Rude RK, Shils ME. Magnesium. In: Shils ME, editor. Modern nutrition in health and disease. Philadelphia, PA: Lippincott, Williams & Wilkins; 2006.
8. Bygrave FL. Cellular calcium and magnesium metabolism. In: Williams DL, editor. An introduction to bio-inorganic chemistry. Thomas; 1976. p. 171-84.
9. Wolf FI, Trapani V. Cell (patho)physiology of magnesium. Clin Sci 2008;114:27-35.
10. Schroll A. Advances in magnesium research. London: John Libbey & Co.; 2002.
11. Durlach J, Durlach V, Bac P, Bara M, Guiet-Bara A. Magnesium and therapeutics. Magnes Res 1994;7:313-28.
12. Cunningham J, Rodriguez JM, Messa P. Magnesium in chronic kidney disease stages 3 and 4, and in dialysis patients. Clin Kidney J 2012;5:i39-51.
13. Herzog P, Holtermuller KH. Antacid therapy - changes in mineral metabolism. Scand J Gastroenterol Suppl 1982;75:56-62.
14. Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9.
15. Zhang Z, Egaña JT, Reckhenrich AK, Schenck TL, Lohmeyer JA, Schantz JT, et al. Cell-based resorption assays for bone graft substitutes. Acta Biomater 2012;8:13-9.
16. Staiger MP, Pietak AM, Huadmai J, Dias G. Magnesium and its alloys as orthopedic biomaterials: a review. Biomaterials 2006;27:1728-34.
17. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth CJ, et al. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005;26:3557-63.
18. 10993-5:2009 I. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity 2009.
19. 10993-12:2012 I. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials 2012.
20. Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM, et al. Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 2004;25:3963-72.
21. Collins TJ. ImageJ for microscopy. Biotechniques 2007;43:25-30.
22. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c- Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999;190:1741-54.
23. Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N. The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 2001;232:235-47.
24. Winkler T, Hoenig E, Gildenhaar R, Berger G, Fritsch D, Janssen R, et al. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities. Acta Biomater 2010;6:4127-35.
25. Zhang Z, Egana JT, Reckhenrich AK, Schenck TL, Lohmeyer JA, Schantz JT, et al. Cell-based resorption assays for bone graft substitutes. Acta Biomater 2012;8:13-9.
26. Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab 2012;23:582-90.
27. Mansky KC, Sulzbacher S, Purdom G, Nelsen L, Hume DA, Rehli M, et al. The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter. J Leukoc Biol 2002;71:304-10.
28. Troen BR. The regulation of cathepsin K gene expression. Ann NY Acad Sci 2006;1068:165-72.
29. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005;106:852-9.
30. Berridge MV, Tan AS. Trans-plasma membrane electron transport: a cellular assay for NADH- and NADPH-oxidase based on extracellular, superoxidemediated reduction of the sulfonated tetrazolium salt WST-1. Protoplasma 1998;205:74-82.
31. Rubin H. Central role for magnesium in coordinate control of metabolism and growth in animal cells. Proc Natl Acad Sci USA 1975;72:3551-5.
32. Sgambato A, Faraglia B, Ardito R, Torsello A, Boninsegna A, Cittadini A, et al. Isolation of normal epithelial cells adapted to grow at nonphysiological concentration of magnesium. Biochem Biophys Res Commun 2001;286:752-7.
33. Maier JA, Bernardini D, Rayssiguier Y, Mazur A. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta 2004;1689:6-12.
34. Walker GM. Magnesium and cell cycle control: an update. Magnesium 1986;5:9-23.
35. Rubin H. The membrane, magnesium, mitosis (MMM) model of cell proliferation control. Magnes Res 2005;18:268-74.
36. Saylor P, Wang C, Hirai TJ, Adams JA. A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps. Biochemistry 1998;37:12624-30.
37. Belluci MM, Schoenmaker T, Rossa-Junior C, Orrico SR, de Vries TJ, Everts V. Magnesium deficiency results in an increased formation of osteoclasts. J Nutr Biochem 2013;24:1488-98.
38. Hayman AR, Warburton MJ, Pringle JA, Coles B, Chambers TJ. Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas. Biochem J 1989;261:601-9.
39. Marie PJ, Hott M. Effect of calcitonin on the magnesium-induced bone resorption in the mouse. Magnesium 1987;6:100-8.
40. Marie PJ, Travers R, Delvin EE. Influence of magnesium supplementation on bone turnover in the normal young mouse. Calcif Tissue Int 1983;35:755-61.
41. Shinohara M, Nakamura M, Masuda H, Hirose J, Kadono Y, Iwasawa M, et al. Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport. J Bone Miner Res 2012;27:2464-75.
42. Sugatani T, Hruska KA. Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 2005;280:3583-9.
43. Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 2003;10:1165-77.
44. Novack DV, Faccio R. Osteoclast motility: putting the brakes on bone resorption. Ageing Res Rev 2011;10:54-61.
45. Holt I, Marshall MJ. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface. J Cell Physiol 1998;175:1-9.
46. Minkin C, Marinho VC. Role of the osteoclast at the bone-implant interface. Adv Dent Res 1999;13:49-56.
47. Shankar G, Davison I, Helfrich MH, Mason WT, Horton MA. Integrin receptormediated mobilisation of intranuclear calcium in rat osteoclasts. J Cell Sci 1993;105(1):61-8.
48. Takeichi M, Okada TS. Roles of magnesium and calcium ions in cell-tosubstrate adhesion. Exp Cell Res 1972;74:51-60.
49. Elices MJ, Urry LA, Hemler ME. Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg- Gly-Asp peptide and by divalent cations. J Cell Biol 1991;112:169-81.
50. Rubin AH, Terasaki M, Sanui H. Major intracellular cations and growth control: correspondence among magnesium content, protein synthesis, and the onset of DNA synthesis in BALB/c3T3 cells. Proc Natl Acad Sci USA 1979;76:3917-21.
51. Bowen-Pope DF, Vidair C, Sanui H, Rubin AH. Separate roles for calcium and magnesium in their synergistic effect on uridine uptake by cultured cells: significance for growth control. Proc Natl Acad Sci USA 1979;76:1308-12.
52. Arnett TR. Extracellular pH regulates bone cell function. J Nutr 2008;138:415S-8S.
53. Goldhaber P, Rabadjija L. H+ stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol 1987;253:E90-8.
54. Shibutani T, Heersche JN. Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts. J Bone Miner Res 1993;8:331-6.
55. Bessac BF, Fleig A. TRPM7 channel is sensitive to osmotic gradients in human kidney cells. J Physiol 2007;582:1073-86.
56. Chen H-C, Xie J, Zhang Z, Su L-T, Yue L, Runnels LW. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One 2010;5:e11161.
57. Hartzell HC, White RE. Effects of magnesium on inactivation of the voltagegated calcium current in cardiac myocytes. J Gen Physiol 1989;94:745-67.
58. Miyauchi A, Hruska KA, Greenfield EM, Duncan R, Alvarez J, Barattolo R, et al. Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption. J Cell Biol 1990;111:2543-52.
59. Janning C, Willbold E, Vogt C, Nellesen J, Meyer-Lindenberg A, Windhagen H, et al. Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling. Acta Biomater 2010;6:1861-8.
60. Huehnerschulte TA, Reifenrath J, von Rechenberg B, Dziuba D, Seitz JM, Bormann D, et al. In vivo assessment of the host reactions to the biodegradation of the two novel magnesium alloys ZEK100 and AX30 in an animal model. Biomed Eng Online 2012;11:14.
61. Lange T, Schilling AF, Peters F, Haag F, Morlock MM, Rueger JM, et al. Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. Biomaterials 2009;30:5312-8.
62. Lange T, Schilling AF, Peters F, Mujas J, Wicklein D, Amling M. Size dependent induction of proinflammatory cytokines and cytotoxicity of particulate betatricalciumphosphate in vitro. Biomaterials 2011;32:4067-75.